Madrigal Pharmaceuticals, Inc. (MDGL)

Madrigal Pharmaceuticals Revenue

In the year 2024, Madrigal Pharmaceuticals had annual revenue of $180.13M. Madrigal Pharmaceuticals had revenue of $103.32M in the quarter ending December 31, 2024.

• Revenue (ttm): $180.13M
• Revenue Growth: n/a
• P/S Ratio: 38.72
• Revenue / Employee: $341,161
• Employees: 528
• Market Cap: 7.19B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	180.13M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.